Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand.

PubWeight™: 1.69‹?› | Rank: Top 3%

🔗 View Article (PMID 10604468)

Published in Nature on December 09, 1999

Authors

J Tormo1, K Natarajan, D H Margulies, R A Mariuzza

Author Affiliations

1: Center for Advanced Research in Biotechnology, University of Maryland Biotechnology Institute, Rockville 20850, USA.

Articles citing this

Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol (2011) 1.85

Nonstochastic coexpression of activation receptors on murine natural killer cells. J Exp Med (2000) 1.65

Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. Proc Natl Acad Sci U S A (2001) 1.60

Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol (2009) 1.54

Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat Rev Immunol (2008) 1.50

Coreceptor restriction within the HLA-DQ locus for Epstein-Barr virus infection. Proc Natl Acad Sci U S A (2000) 1.32

Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J Immunol (2010) 1.24

Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med (2000) 1.23

Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position. J Immunol (2009) 1.18

Mutational analysis of the HLA class II interaction with Epstein-Barr virus glycoprotein 42. J Virol (2003) 1.18

Acquisition of external major histocompatibility complex class I molecules by natural killer cells expressing inhibitory Ly49 receptors. J Exp Med (2001) 1.18

Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci U S A (2007) 1.17

The functional binding site for the C-type lectin-like natural killer cell receptor Ly49A spans three domains of its major histocompatibility complex class I ligand. J Exp Med (2001) 1.17

H-2D ligand expression by Ly49A+ natural killer (NK) cells precludes ligand uptake from environmental cells: implications for NK cell function. J Exp Med (2001) 1.15

Distinct conformations of Ly49 natural killer cell receptors mediate MHC class I recognition in trans and cis. Immunity (2009) 1.07

Stable masking by H-2Dd cis ligand limits Ly49A relocalization to the site of NK cell/target cell contact. Proc Natl Acad Sci U S A (2007) 1.05

Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors. Semin Immunol (2006) 0.99

Molecular architecture of the major histocompatibility complex class I-binding site of Ly49 natural killer cell receptors. J Biol Chem (2008) 0.99

Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors. J Immunol (2009) 0.98

NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors. Blood (2004) 0.97

Conserved C-terminal residues within the lectin-like domain of LOX-1 are essential for oxidized low-density-lipoprotein binding. Biochem J (2001) 0.95

Structural basis for recognition of cellular and viral ligands by NK cell receptors. Front Immunol (2014) 0.94

Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-D(d). J Exp Med (2000) 0.93

Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol (2006) 0.93

Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. J Virol (2008) 0.93

Different vaccine vectors delivering the same antigen elicit CD8+ T cell responses with distinct clonotype and epitope specificity. J Immunol (2009) 0.92

Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site. Proc Natl Acad Sci U S A (2011) 0.92

Ly49 receptors: innate and adaptive immune paradigms. Front Immunol (2014) 0.91

Modulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complex. Front Immunol (2013) 0.91

Natural killer cell licensing in mice with inducible expression of MHC class I. Proc Natl Acad Sci U S A (2013) 0.90

Ly49Q, a member of the Ly49 family that is selectively expressed on myeloid lineage cells and involved in regulation of cytoskeletal architecture. Proc Natl Acad Sci U S A (2004) 0.90

How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J Biomed Biotechnol (2011) 0.90

The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains. J Virol (2009) 0.90

Characteristics of Epstein-Barr virus envelope protein gp42. Virus Genes (2010) 0.89

Ly49-dependent NK cell licensing and effector inhibition involve the same interaction site on MHC ligands. J Immunol (2011) 0.88

The structural basis of ligand recognition by natural killer cell receptors. J Biomed Biotechnol (2011) 0.87

Stress signals activate natural killer cells. J Exp Med (2002) 0.86

Targeting of a natural killer cell receptor family by a viral immunoevasin. Nat Immunol (2013) 0.86

The lectin-like receptor KLRE1 inhibits natural killer cell cytotoxicity. J Exp Med (2003) 0.86

Characterization of murine cytomegalovirus m157 from infected cells and identification of critical residues mediating recognition by the NK cell receptor Ly49H. J Immunol (2008) 0.86

Identification of natural killer cell receptor clusters in the platypus genome reveals an expansion of C-type lectin genes. Immunogenetics (2009) 0.85

Dynamics of free versus complexed β2-microglobulin and the evolution of interfaces in MHC class I molecules. Immunogenetics (2012) 0.84

Molecular cloning of KLRI1 and KLRI2, a novel pair of lectin-like natural killer-cell receptors with opposing signalling motifs. Immunogenetics (2005) 0.82

Analysis of part of the chicken Rfp-Y region reveals two novel lectin genes, the first complete genomic sequence of a class I alpha-chain gene, a truncated class II beta-chain gene, and a large CR1 repeat. Immunogenetics (2003) 0.82

Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance. J Immunol (2013) 0.82

High allelic polymorphism, moderate sequence diversity and diversifying selection for B-NK but not B-lec, the pair of lectin-like receptor genes in the chicken MHC. Immunogenetics (2008) 0.80

Structure of NKp65 bound to its keratinocyte ligand reveals basis for genetically linked recognition in natural killer gene complex. Proc Natl Acad Sci U S A (2013) 0.80

Essential role of the Ly49A stalk region for immunological synapse formation and signaling. Proc Natl Acad Sci U S A (2009) 0.79

MHC molecules lead many lives. Workshop on MHC Class I Molecules at the interface between Biology & Medicine. EMBO Rep (2008) 0.79

A positive cooperativity binding model between Ly49 natural killer cell receptors and the viral immunoevasin m157: kinetic and thermodynamic studies. J Biol Chem (2013) 0.79

Cattle Ly49 is polymorphic. Immunogenetics (2009) 0.78

Recognition of class I MHC by a rat Ly49 NK cell receptor is dependent on the identity of the P2 anchor amino acid of bound peptide. J Immunol (2011) 0.76

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I. Immunity (2016) 0.76

The activating Ly49W and inhibitory Ly49G NK cell receptors display similar affinities for identical MHC class I ligands. Immunogenetics (2014) 0.76

Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules. Med Microbiol Immunol (2005) 0.75

Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C. J Biol Chem (2016) 0.75

Articles by these authors

Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11

A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet (1977) 5.65

Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science (1986) 4.94

The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol (1993) 4.35

Structure and expression of a mouse major histocompatibility antigen gene, H-2Ld. Proc Natl Acad Sci U S A (1982) 3.73

Exon shuffling: mapping polymorphic determinants on hybrid mouse transplantation antigens. Nature (1982) 3.34

Somatic cell hybridization of mouse myeloma cells. Cell (1976) 3.17

T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science (1994) 2.81

Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer. J Immunol (1983) 2.45

Crystal structure of the beta chain of a T cell antigen receptor. Science (1995) 2.37

The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34

Control of expression of histocompatibility antigens (H-2) and beta 2-microglobulin in F9 teratocarcinoma stem cells. Proc Natl Acad Sci U S A (1981) 2.22

Bound water molecules and conformational stabilization help mediate an antigen-antibody association. Proc Natl Acad Sci U S A (1994) 2.18

Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw (1996) 2.18

Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHC-peptide-TCR complex. Immunity (2000) 2.13

Structure and function of the T-cell receptor: insights from X-ray crystallography. Immunol Today (1996) 2.02

"Exon-shuffling" maps control of antibody- and T-cell-recognition sites to the NH2-terminal domain of the class II major histocompatibility polypeptide A beta. Proc Natl Acad Sci U S A (1985) 1.93

Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues. J Exp Med (1994) 1.74

Allospecific and virus-specific cytolytic T lymphocytes are restricted to the N or C1 domain of H-2 antigens expressed on L cells after DNA-mediated gene transfer. Proc Natl Acad Sci U S A (1983) 1.74

Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system. Springer Semin Immunopathol (2000) 1.71

The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure. Science (1986) 1.68

Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68

Hybrid H-2 histocompatibility gene products assign domains recognized by alloreactive T cells. Proc Natl Acad Sci U S A (1983) 1.67

Preferential V beta gene usage and lack of junctional sequence conservation among human T cell receptors specific for a tetanus toxin-derived peptide: evidence for a dominant role of a germline-encoded V region in antigen/major histocompatibility complex recognition. J Exp Med (1992) 1.66

Membrane Ia expression and antigen-presenting accessory cell function of L cells transfected with class II major histocompatibility complex genes. J Exp Med (1984) 1.65

Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule. J Immunol (1995) 1.58

Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. Neoplasia (2001) 1.56

H-2-like genes in the Tla region of mouse chromosome 17. Nature (1982) 1.54

Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution. J Biol Chem (1991) 1.54

T-cell recognition of a chimaeric class II/class I MHC molecule and the role of L3T4. Nature (1985) 1.53

Identification of seven hydrophobic clusters in GCN4 making redundant contributions to transcriptional activation. Mol Cell Biol (1996) 1.47

Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med (1992) 1.46

Three-dimensional structure determination of an anti-2-phenyloxazolone antibody: the role of somatic mutation and heavy/light chain pairing in the maturation of an immune response. EMBO J (1990) 1.44

Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex. J Exp Med (1992) 1.43

Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. J Immunol (1995) 1.42

Magnetic resonance imaging, Down's syndrome and Alzheimer's disease: research and clinical implications. J Intellect Disabil Res (2003) 1.42

Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42

Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J Mol Biol (1996) 1.41

A T cell receptor transgenic model of severe, spontaneous organ-specific autoimmunity. Eur J Immunol (2001) 1.41

A mutational analysis of binding interactions in an antigen-antibody protein-protein complex. Biochemistry (1998) 1.39

A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor beta chain and major histocompatibility complex class II. J Exp Med (1998) 1.39

Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope protein. J Exp Med (1989) 1.35

Three-dimensional structure of an antigen-antibody complex at 6 A resolution. Nature (1985) 1.34

Molecular basis of antigen mimicry by an anti-idiotope. Nature (1995) 1.32

Lysine 271 in the transmembrane domain of the T-cell antigen receptor beta chain is necessary for its assembly with the CD3 complex but not for alpha/beta dimerization. J Biol Chem (1990) 1.29

Regulation of immunoglobulin expression in mouse myeloma cells. Cold Spring Harb Symp Quant Biol (1977) 1.28

H-2 hemizygous mutants from a heterozygous cell line: role of mitotic recombination. EMBO J (1983) 1.28

Minimal requirements for peptide mediated activation of CD8+ CTL. Mol Immunol (1994) 1.28

Host MHC class I molecules modulate in vivo expression of a NK cell receptor. J Immunol (1994) 1.25

Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules. Nature (1991) 1.22

Functional expression of a transfected murine class II MHC gene. Nature (1984) 1.22

Crystal structure of the V alpha domain of a T cell antigen receptor. Science (1995) 1.21

Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry (1995) 1.20

Post-thymectomy autoimmune gastritis: fine specificity and pathogenicity of anti-H/K ATPase-reactive T cells. Eur J Immunol (1999) 1.20

Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J Immunol (1998) 1.20

Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Proc Natl Acad Sci U S A (1995) 1.20

Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS. NMR Biomed (2008) 1.19

A mutational analysis of the binding of two different proteins to the same antibody. Biochemistry (1996) 1.18

A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity (1995) 1.17

Two intermediate-avidity cytotoxic T lymphocyte clones with a disparity between functional avidity and MHC tetramer staining. Int Immunol (2001) 1.17

Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol (2000) 1.17

Superantigen binding to a T cell receptor beta chain of known three-dimensional structure. J Exp Med (1995) 1.16

The natural killer cell receptor Ly-49A recognizes a peptide-induced conformational determinant on its major histocompatibility complex class I ligand. Proc Natl Acad Sci U S A (1996) 1.15

Thermodynamics of antigen-antibody binding using specific anti-lysozyme antibodies. Eur J Biochem (1995) 1.14

Estimation of the hydrophobic effect in an antigen-antibody protein-protein interface. Biochemistry (2000) 1.14

The structure of the T cell antigen receptor. Annu Rev Immunol (1996) 1.14

The inducible N-acetylglucosamine catabolic pathway gene cluster in Candida albicans: discrete N-acetylglucosamine-inducible factors interact at the promoter of NAG1. Proc Natl Acad Sci U S A (2000) 1.14

Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. J Biol Chem (1993) 1.13

H-2Dd exploits a four residue peptide binding motif. J Exp Med (1993) 1.13

Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC. Cell (1989) 1.12

High affinity T cell receptors from yeast display libraries block T cell activation by superantigens. J Mol Biol (2001) 1.10

Oxalate decarboxylase from Collybia velutipes. Molecular cloning and its overexpression to confer resistance to fungal infection in transgenic tobacco and tomato. J Biol Chem (2000) 1.10

Anatomy of an antibody molecule: structure, kinetics, thermodynamics and mutational studies of the antilysozyme antibody D1.3. Immunol Rev (1998) 1.10

Intracranial volume change in childhood. J Neurosurg (1999) 1.09

Solvent rearrangement in an antigen-antibody interface introduced by site-directed mutagenesis of the antibody combining site. J Mol Biol (1994) 1.08

The structural basis of antigen-antibody recognition. Annu Rev Biophys Biophys Chem (1987) 1.08

Luxury accommodations: the expanding role of structural plasticity in protein-protein interactions. Structure (2000) 1.08

Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin. Proc Natl Acad Sci U S A (1992) 1.07

Control of autoimmunity by regulatory T cells. Adv Exp Med Biol (2001) 1.07

Structural features of nonpeptide prenyl pyrophosphates that determine their antigenicity for human gamma delta T cells. J Immunol (2001) 1.06

Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants. J Immunol (1986) 1.06

Crystal structure of human CD69: a C-type lectin-like activation marker of hematopoietic cells. Biochemistry (2000) 1.06

Ocular chlamydial infections. Clinicomicrobiological correlation. Cornea (1996) 1.05

Independent and synergistic effects of disulfide bond formation, beta 2-microglobulin, and peptides on class I MHC folding and assembly in an in vitro translation system. J Immunol (1992) 1.05

Role of the T cell receptor ligand affinity in T cell activation by bacterial superantigens. J Biol Chem (2001) 1.05

Role of the T cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity (1999) 1.04

Analysis of binding interactions in an idiotope-antiidiotope protein-protein complex by double mutant cycles. Biochemistry (1997) 1.04

Linkage of beta 2-microglobulin and ly-m11 by molecular cloning and DNA-mediated gene transfer. Proc Natl Acad Sci U S A (1983) 1.04

Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor. Nature (1998) 1.04

Genetic diversity of ectomycorrhizal Basidiomycetes from African and Indian tropical rain forests. Mycorrhiza (2007) 1.03

Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,). Biochemistry (2000) 1.03

MHC class I molecules, structure and function. Rev Immunogenet (1999) 1.03

Intracranial volume change in craniosynostosis. J Neurosurg (1999) 1.02

Interaction of the NK cell inhibitory receptor Ly49A with H-2Dd: identification of a site distinct from the TCR site. Immunity (1999) 1.02

Three-dimensional structure of H-2Dd complexed with an immunodominant peptide from human immunodeficiency virus envelope glycoprotein 120. J Mol Biol (1998) 1.01